Thomas Daniel

Thomas Daniel

Directeur/Membre du Conseil chez GOSSAMER BIO, INC.

Fortune : 8 800 $ au 31/05/2026

72 ans
Health Technology
Consumer Services
Commercial Services

Profil

Thomas O.
Daniel
is currently Chairman-Overseers Board at The Scripps Research Institute; Chairman at Locanabio, Inc., Life Science Cares San Diego LLC, Gate Therapeutics, and Trotana, Inc.; Director at FerruMax Pharmaceuticals, Inc. and Lupus Research Alliance, Inc.; Independent Director at Gossamer Bio, Inc.; Director at Aspen Neuroscience, Inc. and Mozart Therapeutics, Inc.; and Trustee at The Reed Institute.
Former roles include Chairman-Research Division at Celgene Corp., Independent Director at Zafgen, Inc., Director at Abide Therapeutics, Inc., PharmAkea, Inc., Alliance for Lupus Research, Pharmaceutical Research & Manufacturers of America, Epizyme, Inc., ImmusanT, Inc., Magenta Therapeutics, Inc., Vir Biotechnology, Inc., Vanderbilt Vascular Biology Center, Sana Biotechnology, Inc., Vividion Therapeutics, Inc., and Larimar Therapeutics, Inc.; Chief Scientific Officer & Director at Ambrx, Inc.; Independent Director at Juno Therapeutics, Inc.; Executive Director at Catalyst Advisors LP; Vice President-Research at Amgen, Inc.; Senior Vice President-Discovery Research at Immunex Corp.; Venture Partner at ARCH Venture Partners LLC; and Professor at Vanderbilt University.
Education includes an undergraduate degree from Southern Methodist University (1974) and doctorates from The University of Texas at Austin and The University of Texas Southwestern Medical Center (both 1978).

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
04/06/2026 38 095 ( 0,01 % ) 8 800 $ 31/05/2026

Postes actifs de Thomas Daniel

SociétésPosteDébut
GOSSAMER BIO, INC. Directeur/Membre du Conseil 01/01/2018
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 01/02/2020
Directeur/Membre du Conseil 01/06/2020
Président -
Directeur/Membre du Conseil 01/03/2017
Président -
Corporate Officer/Principal -
Directeur/Membre du Conseil -

Anciens postes connus de Thomas Daniel

SociétésPosteFin
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Thomas Daniel

Formation de Thomas Daniel

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

86

Relations au 1er degré

34

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées34

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Services

Technology Services

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. Thomas Daniel
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇